Features November 2011 Issue

Research Gives Hope to Patients With Rare Vascular Cancer

Cleveland Clinic researchers suggest that their work could lead to breakthroughs in treating other cancers.

An international research effort, led by a Cleveland Clinic doctor, has discovered the specific genetic alteration that is believed to cause a rare, but devastating vascular cancer. Brian Rubin, MD, PhD, of Cleveland Clinic’s Pathology and Laboratory Medicine Institute and Lerner Research Institute, helped devise an innovative approach to reveal the genetic clues to epithelioid hemangioendothelioma (EHE). The research was published in the Aug. 31 issue of Science Translational Medicine, and was done in collaboration with Cleveland Clinic’s Taussig Cancer Institute. The findings are also being used to develop a new diagnostic test for this blood vessel disease.

To continue reading this article you must be a paid subscriber.

Subscribe to Heart Advisor

Get the next year of HEART ADVISOR for just $20. That's a savings of $19 off the regular rate.

With your paid subscription you will receive unlimited access to all of our online content. That is over a decade of previous issues from Cleveland Clinic, the hospital rated #1 in cardiac care by U.S. News & World Report - free of charge.

Subscriber Log In

Forgot your password? Click Here.

Already subscribe but haven't registered for all the benefits of the website? Click here.